The starting dose should be reduced to 25 mg once daily in patients receiving weak CYP3A4 inhibitors (such as erythromycin, saquinavir, verapamil, and fluconazole). Inspra (eplerenone tablets ...
A written informed consent will be provided by each eligible participant, who will be randomly assigned in a double blind fashion to receive eplerenone 25 mg once daily (given in the morning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback